Applied Genetic Techs

(NASDAQ:AGTC)

$0.3936

0.0048[1.23%]

At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here

$0.37

-0.0236[-6.00%]

After Hours: 9:09AM EDT

Day Range0.37 - 0.4	52 Wk Range0.23 - 2.83	Open / Close0.37 / 0.39	Float / Outstanding67.4M / 67.6M
Vol / Avg.757.8K / 1.3M	Mkt Cap26.6M	P/E-	50d Avg. Price0.33
Div / Yield-	Payout Ratio-	Total Float67.4M	EPS-0.28

Applied Genetic Techs Stock (NASDAQ:AGTC), Quotes and News Summary

Q: What sector and industry does Applied Genetic Techs (AGTC) operate in?

Applied Genetic Techs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Applied Genetic Techs Stock (NASDAQ: AGTC) stock price, news, charts, stock research, profile.

Day Range0.37 - 0.4	52 Wk Range0.23 - 2.83	Open / Close0.37 / 0.39	Float / Outstanding67.4M / 67.6M
Vol / Avg.757.8K / 1.3M	Mkt Cap26.6M	P/E-	50d Avg. Price0.33
Div / Yield-	Payout Ratio-	Total Float67.4M	EPS-0.28

Sector: Health Care.Industry: Biotechnology

Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 and ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology, and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

Earnings

Q2 2023		Est.		Actual		Surprise
EPS		(EXPECTED)2023-02-13
REV		(EXPECTED)2023-02-13

Q1 2023		Est.		Actual		Surprise
EPS		-0.280		-0.280		0.0000
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

How do I buy Applied Genetic Techs (AGTC) stock?

You can purchase shares of Applied Genetic Techs (NASDAQ: AGTC) through any online brokerage.

View our list of the best stock brokerages.

Who are Applied Genetic Techs's (AGTC) competitors?

Other companies in Applied Genetic Techs’s space includes: Comera Life Sciences (NASDAQ:CMRA), Celyad Oncology (NASDAQ:CYAD), VistaGen Therapeutics (NASDAQ:VTGN), Gelesis Holdings (NYSE:GLS) and ABVC BioPharma (NASDAQ:ABVC).

What is the target price for Applied Genetic Techs (AGTC) stock?

The latest price target for Applied Genetic Techs (NASDAQ: AGTC) was reported by Wells Fargo on Tuesday, October 25, 2022. The analyst firm set a price target for 0.40 expecting AGTC to rise to within 12 months (a possible 1.63% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Applied Genetic Techs (AGTC)?

The stock price for Applied Genetic Techs (NASDAQ: AGTC) is $0.3936 last updated Today at November 30, 2022, 9:00 PM UTC.

Does Applied Genetic Techs (AGTC) pay a dividend?

There are no upcoming dividends for Applied Genetic Techs.

When is Applied Genetic Techs (NASDAQ:AGTC) reporting earnings?

Applied Genetic Techs’s Q2 earnings are confirmed for Monday, February 13, 2023.

Is Applied Genetic Techs (AGTC) going to split?

There is no upcoming split for Applied Genetic Techs.

What sector and industry does Applied Genetic Techs (AGTC) operate in?

Applied Genetic Techs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SPY

QQQ

BTC/USD

DIA

GLD

TLT

SPY

QQQ